Simulations Plus, Inc.Equity-NMS: SLP
Equity-NMS: SLP
$29.02
-0.99
(18 Dec)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$29.02
Open
$29.02
Today’s high
$30.68
Today’s low
$28.97
52W low
$27.07
52W high
$51.1426
1Y
-29.07%
5Y
-3.52%
PE
61.31
Div yield
0.80%
EPS (TTM)
0.49
Shares O/S
20.07M
Market cap
582.35M
Insights
SLP has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
SLP price is below its 200 day moving average
SLP PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Simulations Plus, Inc.

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer.

Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. The Company also provides tech-enabled training and compliance solutions for clinical trial investigators and site staff. .


FAQs

Can I buy Simulations Plus, Inc. shares in India?
How to buy Simulations Plus, Inc. shares in India?
What is the share price of Simulations Plus, Inc.?
What is the Market Capitalization of Simulations Plus, Inc.?
What is the PE ratio of Simulations Plus, Inc.?
Is Simulations Plus, Inc. a good stock to buy?
In which sector / industry does Simulations Plus, Inc. operate?